Nocturnal dialysis

Dialyze Direct Expands SNF Home Dialysis Program to Kentucky

Retrieved on: 
Monday, March 8, 2021
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Home hemodialysis, Dialysis, Hemodialysis, Nocturnal dialysis

"Over the past few months, we have had the privilege of working closely with the Kentucky Department of Health by participating in their pilot program for SNF home hemodialysis," said Josh Rothenberg, Dialyze Direct's Chief Operating Officer.

Key Points: 
  • "Over the past few months, we have had the privilege of working closely with the Kentucky Department of Health by participating in their pilot program for SNF home hemodialysis," said Josh Rothenberg, Dialyze Direct's Chief Operating Officer.
  • Dialyze Direct provides comprehensive, turn-key home dialysis solutions that allow patients with end-stage renal disease (ESRD) to take advantage of the latest in patient-centric dialysis care.
  • Kentuckymarks the eleventh state in which Dialyze Direct is active, with expansion slated for several additional states within the next year.
  • Dialyze Direct has operations inFlorida,Illinois,Indiana,Kentucky, Maryland,New Jersey,New York,Ohio,Pennsylvania,Tennessee, and Texas and is in the process of launching operations in additional states.

Bhajan S. Dara, MD, FACP, FASN, is recognized by Continental Who's Who

Retrieved on: 
Tuesday, August 25, 2020
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Detoxification, Dialysis, Nocturnal dialysis

Specializing in the care and treatment of the kidneys, he currently serves as the medical director of two dialysis facilities.

Key Points: 
  • Specializing in the care and treatment of the kidneys, he currently serves as the medical director of two dialysis facilities.
  • He opened Metro St. Louis Dialysis Center in 2003, having cared for thousands of patients in North St. Louis.
  • In 2007, he partnered with American Renal Associates, LLC to bring the most comprehensive, state-of-the-art dialysis treatments to the community.
  • Highly in demand, Dr. Dara also cares for patients at Saint Mary's Hospital, DePaul Hospital and Saint Clare Hospital.

Hemodialysis and Peritoneal Dialysis Market to Garner $22.16 Bn, Globally, by 2027 at 6.0% CAGR, Says Allied Market Research

Retrieved on: 
Tuesday, August 11, 2020
Clinical medicine, Medicine, Renal dialysis, Membrane technology, Nephrology, Detoxification, Dialysis, Home hemodialysis, Hemodialysis, Peritoneal dialysis, Northwest Kidney Centers, Nocturnal dialysis

PORTLAND, Ore., Aug. 11, 2020 /PRNewswire/ -- Allied Market Research recently published a report, " Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 20202027".

Key Points: 
  • PORTLAND, Ore., Aug. 11, 2020 /PRNewswire/ -- Allied Market Research recently published a report, " Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 20202027".
  • However, the peritoneal dialysis segment is expected to manifest the highest CAGR of 7.2% from 2020 to 2027.
  • However, the clinics and dialysis centers segment dominated the global hemodialysis and peritoneal dialysis market in 2019, contributing to more than half of the market, as most patients prefer to receive dialysis treatments through services provided by dialysis centers.
  • By region, the global hemodialysis and peritoneal dialysis market across Asia-Pacific, followed by North America, held the largest share in 2019, contributing to more than two-fifths of the market.

Tablo® Hemodialysis System Receives FDA Clearance for Home Dialysis

Retrieved on: 
Thursday, April 2, 2020
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Detoxification, Dialysis, Hemodialysis, Home hemodialysis, Nocturnal dialysis, Northwest Kidney Centers

Currently, more than 500,000 Americans undergo dialysis treatments three or more times each week, typically lasting four hours per treatment.

Key Points: 
  • Currently, more than 500,000 Americans undergo dialysis treatments three or more times each week, typically lasting four hours per treatment.
  • A prospective, multicenter, home hemodialysis trial with 30 patients was completed in 2019 and confirmed the Tablo system is safe and effective for home use.
  • Over the years, he has had thousands of dialysis treatments at various centers as well as on home hemodialysis.
  • Requiring only an electrical outlet and tap water to operate, the mobile Tablo system frees patients and providers from expensive clinic infrastructure.

Hemodialysis and Peritoneal Dialysis Market to Grow at 6.0% CAGR to 2024 - Led by Hospitals and Dialysis Centers

Retrieved on: 
Tuesday, July 30, 2019
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Home hemodialysis, Dialysis, Hemodialysis, Peritoneal dialysis, Nocturnal dialysis, Kt/V

The hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis.

Key Points: 
  • The hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis.
  • Hemodialysis & peritoneal dialysis market is segmented into hemodialysis and peritoneal dialysis.
  • Hemodialysis and peritoneal dialysis market is classified into three major segmentsconventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis (NHD).
  • This report analyzes industry trends, hemodialysis and peritoneal dialysis market shares of top players, and company profiles, which together forma basic view of the market.

Hemodialysis and Peritoneal Dialysis Market to Grow at 6.0% CAGR to 2024 - Led by Hospitals and Dialysis Centers

Retrieved on: 
Tuesday, July 30, 2019
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Home hemodialysis, Dialysis, Hemodialysis, Peritoneal dialysis, Nocturnal dialysis, Kt/V

The hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis.

Key Points: 
  • The hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis.
  • Hemodialysis & peritoneal dialysis market is segmented into hemodialysis and peritoneal dialysis.
  • Hemodialysis and peritoneal dialysis market is classified into three major segmentsconventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis (NHD).
  • This report analyzes industry trends, hemodialysis and peritoneal dialysis market shares of top players, and company profiles, which together forma basic view of the market.

$99.2 Bn Hemodialysis & Peritoneal Dialysis Market by Product, Services, Modality, End User - Global Forecasts to 2024 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 15, 2019
Medical devices, Health, Medicine, Clinical medicine, Renal dialysis, Membrane technology, Hemodialysis, Dialysis, Home hemodialysis, Peritoneal dialysis, CAPD, Catheter, Nocturnal dialysis

The "Hemodialysis & Peritoneal Dialysis Market by Product (Machines, Dialyzers, Concentrates, Dialysates, Catheters) Services, Modality (Conventional, CAPD, Nocturnal), End User - Global Forecasts to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemodialysis & Peritoneal Dialysis Market by Product (Machines, Dialyzers, Concentrates, Dialysates, Catheters) Services, Modality (Conventional, CAPD, Nocturnal), End User - Global Forecasts to 2024" report has been added to ResearchAndMarkets.com's offering.
  • The Hemodialysis and Peritoneal Dialysis Market is Projected to reach USD 99.2 billion by 2024 from USD 74.2 billion in 2019, at a CAGR of 6.0%.
  • The hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis.
  • Based on modality, the hemodialysis market is classified into three major segmentsconventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis (NHD).

Baxter Announces 5 Million Home Dialysis Treatments Managed Globally with Sharesource Remote Patient Management

Retrieved on: 
Thursday, January 17, 2019
Surgery, Health, Clinical trials, Hospitals, Medical devices, Diabetes, FDA, Medicine, Renal dialysis, Membrane technology, Detoxification, Dialysis, Peritoneal dialysis, Nephrology, Kidney, National Kidney Foundation Singapore, Nocturnal dialysis

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced the Sharesource remote patient management platform has performed more than 5 million home peritoneal dialysis (PD) treatments globally.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced the Sharesource remote patient management platform has performed more than 5 million home peritoneal dialysis (PD) treatments globally.
  • View the full release here: https://www.businesswire.com/news/home/20190117005108/en/
    Baxters Sharesource remote patient management platform has logged more than 5 million home peritoneal dialysis treatments globally; milestone is evidence that smarter, more effective innovation is enhancing renal care.
  • Healthcare professionals using the Sharesourceremote patient management platform have more frequent visibility to their patients PD therapy sessions.
  • Comparison of Hospitalization Rate in Automatized Peritoneal Dialysis Patients with and without Remote Management Program in Colombia [Abstract].

New Study Showcases Improved Survival With More Frequent Home Hemodialysis in Incident Dialysis Patients

Retrieved on: 
Tuesday, October 23, 2018
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Home hemodialysis, Hemodialysis, Dialysis, Nocturnal dialysis, NxStage, Dialysis disequilibrium syndrome, Kt/V

"Less than 1% of new dialysis patients each year perform home hemodialysis, according to the USRDS"3 said Dr. Eric Weinhandl, NxStage Clinical Epidemiologist and Biostatistician.

Key Points: 
  • "Less than 1% of new dialysis patients each year perform home hemodialysis, according to the USRDS"3 said Dr. Eric Weinhandl, NxStage Clinical Epidemiologist and Biostatistician.
  • The reported benefits of more frequent home hemodialysis (HHD) may not be experienced by all patients.
  • The NxStage System One is a simple, flexible and portable hemodialysis system that provides a wide range of dialysis therapy options, including home, more frequent, solo, and nocturnal dialysis.
  • Preferences of patients undergoing hemodialysis - results from a questionnaire-based study with 4,518 patients.